SCHEMBL10176157

SCHEMBL10176157

Cc1cc(OCCN2CCN(C)CC2)ccc1[N+](=O)[O-]

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.74
MEN1 O00255 3/20 0.73
KMT2A Q03164 3/20 0.73
HTT P42858 1/20 0.73
ALDH1A1 P00352 7/20 0.70
SMN1; SMN2 Q16637 4/20 0.70
NPC1 O15118 3/20 0.70
RAB9A P51151 3/20 0.70
MAPK1 P28482 2/20 0.62
LMNA P02545 1/20 0.56
MAPT P10636 3/20 0.55
TDP1 Q9NUW8 1/20 0.55
GAA P10253 1/20 0.51
HPGD P15428 1/20 0.51
LTA4H P09960 1/20 0.49
PTGS1 P23219 1/20 0.49
PTGS2 P35354 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14419357 0.94 KDM4E (0.70) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL2953028 0.88 KDM4E (0.89) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL2205189 0.85 SIRT6 (0.58) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL14419242 0.85 KDM4E (0.78) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL216071 0.84 KDM4E (0.54) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL31436960 0.83 KDM4E (0.54) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL10870559 0.82 MAPT (0.71) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL214477 0.81 KDM4E (0.80) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL14419360 0.81 KDM4E (0.63) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL23640213 0.81 MEN1 (0.58) KDM4EMEN1KMT2AHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE48140-E1 Furanone derivative CARNA BIOSCIENCES, INC. (JP) 2020-08-04 US disclosed
EP-2692728-B1 NOVEL FURANONE DERIVATIVE CARNA BIOSCIENCES INC (JP) 2018-07-04 EP disclosed
US-RE46815-E1 Furanone derivative CARNA BIOSCIENCES, INC. (JP) 2018-05-01 US disclosed
CN-103459388-B Novel furanone derivative CARNA BIOSCIENCES, INC. (JP) 2015-11-25 CN disclosed
US-8742113-B2 Furanone derivative SBI BIOTECH CO., LTD. (JP) 2014-06-03 US disclosed
EP-2692728-A1 NOVEL FURANONE DERIVATIVE SBI Biotech Co., Ltd. (JP) 2014-02-05 EP disclosed
US-20140018533-A1 NOVEL FURANONE DERIVATIVE CARNA BIOSCIENCES, INC. (JP) 2014-01-16 US disclosed
CN-103459388-A Novel furanone derivative SBI BIOTECH CO LTD 2013-12-18 CN disclosed
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed
WO-2010122979-A1 THIAZOLIDINONE DERIVATIVE SBIバイオテック株式会社 (JP) 2010-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 KDM4E 2805/4885MEN1 1406/4885KMT2A 3437/4885
US-20140018533-A1 NOVEL FURANONE DERIVATIVE CYP11B1, OXER1, CYP11B2 KDM4E 1886/4885MEN1 427/4885KMT2A 3897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.